DIM Diindolylmethane with BioPerine

Readily available in 4 weeks or less.

Contact Us For Prices(631) 676 – 5537

Diindolylmethane (DIM) with BioPerine is a popular supplement known for its potential to support hormone balance and overall health. DIM is a natural compound found in cruciferous vegetables like broccoli, Brussels sprouts, and kale. It helps the body metabolize estrogen more efficiently, promoting a healthy balance of hormones. This is particularly beneficial for women experiencing symptoms of estrogen dominance, such as PMS, weight gain, and mood swings, as well as for men seeking to maintain healthy estrogen levels. BioPerine, a black pepper extract, is included to enhance the absorption and effectiveness of DIM.

Beyond hormone balance, DIM with BioPerine offers a range of additional health benefits. It has potent anti-inflammatory and antioxidant properties, which help protect cells from damage and reduce the risk of chronic diseases. DIM also supports detoxification processes in the liver, aiding in the elimination of toxins and harmful estrogen metabolites. Moreover, it has been studied for its potential anticancer properties, particularly in relation to hormone-dependent cancers like breast and prostate cancer. The combination of DIM and BioPerine makes this supplement a powerful tool for enhancing overall health and well-being.

Benefits of DIM (Diindolylmethane) with BioPerine:
  • Hormone Balance: Promotes efficient estrogen metabolism and supports healthy hormone levels.
  • Anti-Inflammatory: Reduces inflammation throughout the body.
  • Antioxidant: Protects cells from oxidative stress and damage.
  • Detoxification: Supports liver function and the elimination of toxins.
  • Cancer Prevention: Potentially reduces the risk of hormone-dependent cancers.
  • Enhanced Absorption: BioPerine increases the bioavailability and effectiveness of DIM.
  • Weight Management: Helps regulate weight by balancing hormones.
Consult a healthcare professional before incorporating DIM with BioPerine into your supplement regimen.

These products are not for individual sale. All information provided herein is for informational purposes for B2B product introductions and is not meant as final information. All supplement fact panels must be reviewed prior to being put into commercial use.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCES

    • WebMD: https://www.webmd.com/vitamins/ai/ingredientmono-1049/diindolylmethane
    • WebMD: https://www.webmd.com/vitamins-and-supplements/health-benefits-dim
    • HealthLine: https://www.healthline.com/nutrition/dim-supplement
    • Harvard Health: “By the way, doctor: What does Indolplex do?”
    • Memorial Sloan Kettering Cancer Center: “Diindolylmethane.”
    • Experimental Lung Research: “3,3′-Diindolylmethane attenuates inflammation and fibrosis in radiation-induced lung injury by regulating NF-κB/TGF-β/Smad signaling pathways.”
    • PLoSOne: “Anti-inflammatory activity of diindolylmethane alleviates Riemerella anatipestifer infection in ducks.”
    • Nutrition Reviews: “Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: evidence from experimental and human studies.”
    • EPMA Journal: “First results of the double-blind randomized placebo-controlled multicenter clinical trial of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN).”
    • Cleveland Clinic: “Hormonal Imbalance.”
    • Microbiology Spectrum: “The Anticancer Agent 3,3'-Diindolylmethane Inhibits Multispecies Biofilm Formation by Acne-Causing Bacteria and Candida albicans.”
    • National Cancer Institute: “diindolylmethane.”
    • Cancer Epidemiology, Biomarkers & Prevention: “Single-Dose Pharmacokinetics and Tolerability of Absorption-Enhanced 3, 3′-Diindolylmethane in Healthy Subjects.”
    • Breast Cancer Research and Treatment: “A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.”